Search Results for: LAM Therapeutics Announces Progress of

Articles

- 1/18/2011

Amgen & Xencor to Co-Develop Novel Antibody; Deal Worth $500 Million Xencor, Inc. and Amgen recently announced they will collaborate to...

- 9/12/2012

Cobra Biologics & Algeta Sign Monoclonal Antibody Agreement Cobra Biologics Ltd and Algeta ASA recently announced a new contract manufacturing...

- 11/22/2011

Apricus Biosciences Announces NexACT Partner Has Completed pre-IND Meeting Apricus Biosciences, Inc. recently announced its NexACT out-licensing partner, Exodos Life...

- 11/01/2011

Activartis Develops Cancer Vaccine in Phase II, Seeks Partner Activartis GmbH (formerly Trimed Biotech GmbH) recently announced it is developing...

- 10/17/2011

Oncobiologics Announces Two New Agreements Worth Almost $80 Million Oncobiologics recently announced it has signed two major agreements. The first...

- 2/13/2013

Frost & Sullivan Sees Urgent Need for Cancer Diagnostics Tests; Finds Unmet Need for Key Disorders The range of potential...

- 4/10/2012

Catalent & BASF Join Forces to Solve Bioavailabilty Challenges Catalent Pharma Solutions and BASF recently announced they have entered into...

- 4/3/2012

Aptar Pharma's Device Delivers INSYS Therapeutics' Drug Aptar Pharma recently announced INSYS Therapeutics' SUBSYS, which uses an Aptar Pharma Sublingual...

- 5/24/2011

Sartorius Stedim Biotech & RAUMEDIC Sign Partnership Agreement Sartorius Stedim Biotech (SSB), an international leading pharma and biotech supplier, and...

- 11/28/2012

CoreRx & ViroPro Announce Agreement CoreRx, Inc. and Viropro, Inc. recently announced the two companies have entered into a Reciprocal...